Lung Cancer Screening with Sputum Cytologic Examination, Chest Radiography, and Computed Tomography: An Update for the U.S. Preventive Services Task Force

Established in 1927 by the American College of Physicians

Abstract/Editors' Note | Full Text | PDF

FIGURES/TABLES SUMMARY PAGE

PowerPoint slides are available for most Figures at Annals.org

Lung Cancer Screening with Sputum Cytologic Examination, Chest Radiography, and Computed Tomography: An Update for the U.S. Preventive Services Task Force

View this table:

[in a new window]

Table 1. Controlled Trials of Lung Cancer Screening with Chest Radiography with or without Sputum Cytologic Examination

View this table:

[in a new window]

Table 2. Methods and Quality of Controlled Trials of Lung Cancer Screening

View larger version (20K):

[in a new window]

Figure. Mortality in randomized, controlled trials of lung cancer screening with chest radiography with or without sputum cytologic examination. Follow-up ranged from 3 to 20 years among the 6 studies. The solid black squares represent Mantel–Haenszel weight.

View this table:

[in a new window]

Table 3. Case–Control Studies of Lung Cancer Screening with Chest Radiography and Lung Cancer Mortality Rates

View this table:

[in a new window]

Table 4. Outcomes of Lung Cancer Screening with Low-Dose Computed Tomography

View this table:

[in a new window]

Table 5. Lung Cancer Screening Studies Including Women

View this table:

[in a new window]

Appendix Table 1. Search Strategy

View this table:

[in a new window]

Appendix Table 2. Cohort Studies of Lung Cancer Screening with Chest Radiography